Cencora, Inc. Files 8-K Amendment

Ticker: COR · Form: 8-K/A · Filed: Jul 31, 2024 · CIK: 1140859

Cencora, INC. 8-K/A Filing Summary
FieldDetail
CompanyCencora, INC. (COR)
Form Type8-K/A
Filed DateJul 31, 2024
Risk Levelmedium
Pages3
Reading Time4 min
Sentimentneutral

Sentiment: neutral

Topics: amendment, material-event

TL;DR

Cencora filed an amendment to an 8-K, likely updating material info from Feb 21.

AI Summary

Cencora, Inc. filed an amendment (8-K/A) on July 31, 2024, to a report originally filed on February 21, 2024. This amendment pertains to Item 1.05, which relates to material events. The filing does not provide specific details on the nature of the material event or any associated financial figures.

Why It Matters

This filing is an amendment to a previous report, indicating a potential update or correction to previously disclosed material information that could affect investor understanding of Cencora's business.

Risk Assessment

Risk Level: medium — Amendments to 8-K filings can signal significant, previously undisclosed or corrected material events, requiring investor attention.

Key Players & Entities

FAQ

What specific material event is Cencora, Inc. amending in this 8-K/A filing?

The filing does not specify the exact material event being amended, only that it pertains to Item 1.05 of Form 8-K.

What was the original filing date for the report being amended?

The original report was filed on February 21, 2024.

What is the accession number for this 8-K/A filing?

The accession number is 0001104659-24-084351.

What is Cencora, Inc.'s principal executive office address?

The address is 1 West First Avenue, Conshohocken, PA 19428-1800.

What is the Commission File Number for Cencora, Inc.?

The Commission File Number is 1-6671.

Filing Stats: 924 words · 4 min read · ~3 pages · Grade level 14.2 · Accepted 2024-07-31 16:12:40

Filing Documents

05 Material Cybersecurity Incidents

Item 1.05 Material Cybersecurity Incidents. In the Original Report the Company disclosed that it learned, on February 21, 2024, that data from its information systems had been exfiltrated, some of which may contain personal information. Upon initial detection of the unauthorized activity, the Company immediately took containment steps and commenced an investigation with the assistance of law enforcement, cybersecurity experts and external counsel. Through that investigation, the Company learned that additional data, beyond what was initially identified, had been exfiltrated. The Company has identified and completed its review of most of the exfiltrated data (the "Data"). This review has confirmed that the Data included personally identifiable information ("PII") and protected health information ("PHI") of individuals, most of which is maintained by a Company subsidiary that provides patient support services. For PII and PHI discovered in the Data to date, the Company has provided required notifications to potentially affected parties and individuals as well as regulatory agencies. The Company continues to review the Data and it intends to provide any additional required notifications to affected and potentially affected parties and appropriate regulatory agencies. The Company has no evidence that any of the Data has been or will be publicly disclosed. The Company believes it has contained the incident, and the Company has undertaken remediation efforts, which are ongoing. As part of its remediation efforts, the Company is working with cybersecurity experts to reinforce its systems, strengthen its surveillance of cybersecurity threats and prevent unauthorized occurrences on or conducted through its IT systems. The incident has not had a material impact on the Company's operations, and its information systems have continued to be fully operational. The Company does not believe the incident is reasonably likely to materially impact the Company's financial conditi

Forward-Looking Statements

Forward-Looking Statements Certain of the statements contained in this Current Report on Form 8-K are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Securities Exchange Act"). Words such as "aim," "anticipate," "believe," "can," "continue," "could,", "estimate," "expect," "intend," "may," "might," "on track," "opportunity," "plan," "possible," "potential," "predict," "project," "seek," "should," "strive," "sustain," "synergy," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances and speak only as of the date hereof. These statements are not guarantees of future performance and are based on assumptions and estimates that could prove incorrect or could cause actual results to vary materially from those indicated. A more detailed discussion of the risks and uncertainties that could cause our actual results to differ materially from those indicated is included in (i) the "Risk Factors" and "Management's Discussion and Analysis" sections in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2023 and elsewhere in that report and (ii) other reports filed by the Company pursuant to the Securities Exchange Act. The Company undertakes no obligation to publicly update or revise any forward-looking

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cencora, Inc. July 31, 2024 By: /s/ James F. Cleary Name: James F. Cleary Title: Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing